Powerful Against
Resistant Infections
Faropenem 300mg ER Tablets
- Demonstrates broad spectrum in-vitro antimicrobial activity against many gram-positive & gram negative aerobes & anaerobes, and is resistant to hydrolysis by nearly all beta-lactamases, including extended-spectrum beta-lactamases and AmpC beta-lactamases.
- Has improved chemical stability & reduced CNS effects, compared with imipenem.
- Promising new oral beta-lactam with proven efficacy & safety for the treatment of a variety of community-acquired infections.
Indicated in:
Dosage
300mg twice a day